Respiri Limited (AU:RSH) has released an update.
Respiri Limited, an eHealth SaaS company, has successfully raised an additional A$1.1 million from its shareholders, with the aim of bolstering its US commercialization strategy and to achieve a cashflow breakeven by late 2024. The funds were raised by issuing new shares at a slight premium to the recent closing price, indicating investor confidence in the company’s growth prospects. This capital injection will support initiatives including patient recruitment, cloud-based clinic services, and finalizing risk-share contracts.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
